The GMP-grade mRNA Production Market size was estimated at USD 2.25 billion in 2025 and expected to reach USD 2.74 billion in 2026, at a CAGR of 21.63% to reach USD 8.88 billion by 2032.

Market Leader: AGC Biologics, Inc. leads with 0.00%, ahead of notable competitors including Aldevron, LLC, Anemocyte, Inc., ARCALIS Co., Ltd., and BioNTech SE, among others.
Market Segmentation: The market is segmented by mRNA Type, Delivery System, Production Scale, and Application, offering actionable insights to guide focused growth strategies.
Analytical Highlights: The report delivers in-depth analysis on the Cumulative Impact of Artificial Intelligence (2025), alongside Market Share Analysis, the FPNV Positioning Matrix, and a comprehensive Competitive Analysis. These insights provide clear, actionable guidance on company strategies and evolving market dynamics.

The comprehensive market research report contains extensive data points and includes granular segmentation, key trends, competitive benchmarking, and opportunity mapping to deliver clear, actionable insights. It also provides substantial analytical depth through Market Share Analysis, the FPNV Positioning Matrix, and detailed Company Strategy analysis.

Additionally, the market research report highlights country-level growth patterns, policy and investment impacts, regional market potential, and geopolitical dynamics that shape demand and market access.

GMP-grade mRNA Production Market - Global Forecast 2026-2032